11 results
8-K
EX-99.1
ATAI
ATAI Life Sciences N.V.
4 Jan 24
Regulation FD Disclosure
8:53am
”, Psychiatry Online (2018) Health Volunteer Study Designed for a potential rapid, sustained reduction in depressive symptoms from a single dose
8-K
EX-99.1
ATAI
ATAI Life Sciences N.V.
14 Nov 23
Results of Operations and Financial Condition
12:00am
to initiate a Phase 1b healthy volunteer study and expects to enroll the first participant in 1H 2024.
DMX-1002: Ibogaine for Opioid Use Disorder (OUD)
DMX
10-K
2021 FY
ATAI
ATAI Life Sciences N.V.
30 Mar 22
Annual report
1:48pm
subjects, which preliminarily exhibited pro-cognitive effects on exploratory endpoints in pain patients as well as in two volunteer trials involving
424B4
4qc0eaa bs14
21 Jun 21
Prospectus supplement with pricing info
4:09pm
S-1/A
400ewp b6v
26 May 21
IPO registration (amended)
9:46pm
S-1
vsgi hu66
20 Apr 21
IPO registration
5:13pm
- Prev
- 1
- Next